Groop L, Eriksson C J, Wåhlin-Boll E, Melander A
Eur J Clin Pharmacol. 1984;26(6):723-5. doi: 10.1007/BF00541932.
Chlorpropamide-alcohol flush (CPAF) tests were carried out in 15 male and 15 female Type 2 diabetics. Twelve subjects were CPAF-positive and 18 were -negative. The two groups did not differ in age or duration of diabetes, but the CPAF-positive subjects weighed less (mean difference 13 kg) and had higher plasma chlorpropamide levels. There was a negative correlation between plasma chlorpropamide and body weight, and a positive correlation between plasma chlorpropamide and the increase in facial skin temperature. Females had higher plasma chlorpropamide, a greater skin temperature increase and lower body weight than males; there were 11 females and only 1 male amongst the 12 CPAF-positive subjects. The findings confirm that plasma chlorpropamide is a major determinant of the CPAF reaction and also show that body weight strongly influences the chlorpropamide level and, consequently, the outcome of the CPAF test. The sex difference in body weight probably accounts for most, if not all, of the sex difference in the incidence of the CPAF.
对15名男性和15名女性2型糖尿病患者进行了氯磺丙脲-乙醇潮红(CPAF)试验。12名受试者CPAF呈阳性,18名呈阴性。两组在年龄或糖尿病病程方面无差异,但CPAF阳性受试者体重较轻(平均差异13千克)且血浆氯磺丙脲水平较高。血浆氯磺丙脲与体重呈负相关,与面部皮肤温度升高呈正相关。女性的血浆氯磺丙脲水平较高,皮肤温度升高幅度较大,体重低于男性;在12名CPAF阳性受试者中,有11名女性,仅1名男性。这些发现证实血浆氯磺丙脲是CPAF反应的主要决定因素,还表明体重强烈影响氯磺丙脲水平,进而影响CPAF试验结果。体重的性别差异可能在很大程度上(如果不是全部的话)解释了CPAF发病率的性别差异。